Found: 7
Select item for more details and to access through your institution.
The prognostic value of quantitative bone scan SPECT/CT prior to 223Ra treatment in metastatic castration-resistant prostate cancer (mCRPC).
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.240408
- By:
- Publication type:
- Article
The prognostic value of quantitative bone scan SPECT/CT prior to 223Ra treatment in metastatic castration-resistant prostate cancer (mCRPC).
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.240408
- By:
- Publication type:
- Article
The prognostic value of quantitative bone scan SPECT/CT prior to 223Ra treatment in metastatic castration-resistant prostate cancer (mCRPC).
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.240408
- By:
- Publication type:
- Article
The prognostic value of quantitative bone scan SPECT/CT prior to 223Ra treatment in metastatic castration-resistant prostate cancer (mCRPC).
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.240408
- By:
- Publication type:
- Article
The prognostic value of quantitative bone scan SPECT/CT prior to 223Ra treatment in metastatic castration-resistant prostate cancer (mCRPC).
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.240408
- By:
- Publication type:
- Article
The prognostic value of quantitative bone scan SPECT/CT prior to 223Ra treatment in metastatic castration-resistant prostate cancer (mCRPC).
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.240408
- By:
- Publication type:
- Article
The prognostic value of quantitative bone scan SPECT/CT prior to 223Ra treatment in metastatic castration-resistant prostate cancer (mCRPC).
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.240408
- By:
- Publication type:
- Article